Who owns HAEMONETICS?
- CUSIP Number: 405024ab6
Tip: Access positions for across all investors
Analyze quarterly positions in Haemonetics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Haemonetics stock
Who bought or sold HAEMONETICS this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Tenor Capital Management | 119M | $117M | 0% | Sep 2025 |
|
| Osterweis Capital Management | 49M | $48M | 0% | Sep 2025 |
|
| Franklin Resources | 26M | $25M | -27% | Sep 2025 |
|
| Readystate Asset Management | 16M | $15M | 0% | Sep 2025 |
|
| Millennium Management | 16M | $15M | 100% | Sep 2025 |
|
| Oaktree Capital Management | 9.2M | $9.1M | 105% | Sep 2025 |
|
| DeepCurrents Investment Group | 9.2M | $9.0M | 28% | Sep 2025 |
|
| MacKay Shields | 8.9M | $8.8M | -58% | Sep 2025 |
|
| State Street Corporation | 6.1M | $5.9M | 10% | Sep 2025 |
|
| Angelo, Gordon & Co | 6.0M | $5.9M | 0% | Sep 2025 |
|
| Aviva | 4.9M | $4.8M | 0% | Sep 2025 |
|
| Russell Investments | 3.3M | $3.2M | -3% | Sep 2025 |
|
| BlackRock | 3.0M | $3.0M | 7% | Sep 2025 |
|
| Bnp Paribas Investment Partners | 3.0M | $2.9M | 0% | Sep 2025 |
|
| Toronto-Dominion Bank | 3.0M | $2.9M | 0% | Sep 2025 |
|
| Palisade Capital Management | 2.8M | $2.8M | 10% | Sep 2025 |
|
| Capstone Investment Advisors | 2.6M | $2.5M | 0% | Sep 2025 |
|
| SSI Investment Management | 2.5M | $2.4M | 0% | Sep 2025 |
|
| Aequim Alternative Investments | 2.5M | $2.5M | 0% | Sep 2025 |
|
| Ontario Teachers' Pension Plan Board | 2.0M | $2.0M | 0% | Sep 2025 |
|
| Wells Fargo & Company | 1.7M | $1.7M | -2% | Sep 2025 |
|
| Corbyn Investment Management | 814k | $796k | 9% | Sep 2025 |
|
| Barclays | 419k | $410k | 227% | Sep 2025 |
|
| Zazove Associates | 382k | $374k | 0% | Sep 2025 |
|
| Sei Investments | 335k | $328k | 0% | Sep 2025 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 250k | $245k | 0% | Sep 2025 |
|
| Oppenheimer Asset Management | 192k | $188k | 2% | Sep 2025 |
|
| Calamos Advisors | 108k | $106k | 0% | Sep 2025 |
|
| Jane Street | 108k | $106k | -68% | Sep 2025 |
|
| Beacon Investment Advisors | 78k | $76k | 22% | Sep 2025 |
|
| Leucadia National Corporation | 76k | $74k | 12% | Sep 2025 |
|
| Financial Consulate | 68k | $66k | 100% | Sep 2025 |
|
| Stephens | 59k | $58k | 0% | Sep 2025 |
|
| LPL Financial | 40k | $39k | 0% | Sep 2025 |
|
| Balboa Wealth Partners | 30k | $29k | 0% | Sep 2025 |
|
| Sontag Advisory | 28k | $27k | 33% | Sep 2025 |
|
| Commonwealth Equity Services | 20k | $20k | 0% | Sep 2025 |
|
| Piper Jaffray & Co. | 20k | $20M | 100% | Sep 2025 |
|
| HB Wealth Management | 13k | $13k | 0% | Sep 2025 |
|
| Fifth Third Bancorp | 12k | $1.2M | 100% | Sep 2025 |
|
| Steward Partners Investment Advisory | 7.0k | $6.8k | 0% | Sep 2025 |
|
| Us Bancorp | 6.0k | $5.9k | 0% | Sep 2025 |
|
Who sold out of Haemonetics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jpmorgan Chase & Co | Mar 2025 | 1.0M | $955k |
| American Century Companies | Jun 2025 | 108k | $105k |
| Virtus ETF Advisers | Jun 2025 | 41k | $40k |
| Wiley Bros.-aintree Capital | Jun 2025 | 11k | $11k |